申请人:Johnson Norbert Christopher
公开号:US20050124626A1
公开(公告)日:2005-06-09
The present invention relates to novel quinoline and aza indole compounds having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of CNS and other disorders.
本发明涉及具有药理活性的新奎诺啉和氮杂吲哌化合物,其制备过程,包含它们的组合物以及它们在治疗中枢神经系统和其他疾病中的应用。